Chiral ligand from Synkem
A new ligand for use in the production of chiral pharmaceutical intermediates, developed by France's Synkem, promises improved performance over rival products.
Archives for November 18, 2003
Merck drops investment in biopharma unit
Merck KGaA drops plans to build a €300m biomanufacturing plant in Jena, Germany, on the grounds that late-stage product failures have left plenty of free capacity in the contract sector. The company's move suggests that the often-repeated assertion...
Novo turns to Neose for PEG
Denmark's Novo Nordisk has signed a €47m deal with Neose to develop long-acting versions of three protein drugs using a proprietary PEGylation technology.